- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07526896
Framsteg inom kliniska resultat för hjärtsvikt genom utnyttjande av defibrilleringsledningsimplantatssystem för pacing av vänstra grenområdet (ACHIEVED LBBAP)
Framsteg inom kliniska resultat för hjärtsvikt genom användning av defibrilleringsledningsimplantationssystem för pacing av vänstra grenblocksområdet
This 2x2 randomized crossover feasibility study will evaluate the therapeutic value of adding pacing from the left ventricular lead to Left Bundle Branch Area Pacing (LBBAP) using a cardiac resynchronization therapy defibrillator (CRT-D). This combined therapy is known as Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT) and will be compared to LBBAP therapy over sequential 6-month periods in CRT-indicated patients with LBBB. Primary and secondary outcomes are echocardiographic changes. Exploratory assessments will include NT-proBNP and subject-reported quality of life (KCCQ). An observational treatment arm will include subjects who have not been randomized due to unsuccessful implant for real-world observational analysis
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Robert Stadler
- Telefonnummer: 763-526-0261
- E-post: robert.stadler@medtronic.com
Studieorter
-
-
Minnesota
-
Minneapolis, Minnesota, Förenta staterna, 55407
- Rekrytering
- Minneapolis Heart Institute Foundation
-
Huvudutredare:
- John Zakaib
-
Kontakt:
- Ellen Thomas
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Subject meets current ACC/AHA/HRS guidelines for implantation of a CRT-D device.
- Subject has documented LVEF ≤ 35% within 60 days of enrollment.
- Subject meets the criteria for presence of Strauss-defined LBBB.
- Subject meets NYHA classification II or III.
- Subject is willing and able to provide written consent.
- Subject is at least 18 years of age at the time of consent.
- Subject is geographically stable and willing and able to complete study procedures, including follow-up visits.
- The subject's medical records must be accessible by the enrolling site over the follow-up period.
Exclusion Criteria:
- Subject has documented myocardial infarction before enrollment.
- Subject has non-LBBB conduction patterns such as Right Bundle Branch Block (RBBB) or non-specific IVCD.
- Subject has 2nd or 3rd degree AV block.
- Subject has persistent or permanent atrial fibrillation (AF) or atrial flutter (AFL).
- Subject has intrinsic (non-paced) QRS duration ≤ 120ms.
- Subject with previous or existing pacemaker (including transvenous and transcatheter pacing system), Implantable Cardioverter Defibrillator (ICD, transvenous) or CRT-D (transvenous) device or leads.
- Subject has contraindications for screw-in transvenous lead placement (e.g., mechanical right heart valve).
- Subject underwent valve surgery within 90 days prior to enrollment.
- Subject is unable or unwilling to undergo baseline CMR imaging, if previously collected CMR images are unavailable or do not meet minimum acceptable criteria.
- Subject is post-heart transplantation or is actively listed on the transplantation list.
- Subject is implanted with a left ventricular assist device (LVAD).
- Subject has severe renal disease.
- Subject is on continuous or uninterrupted infusion (inotropic) therapy for heart failure.
- Subject has complex and uncorrected congenital heart disease.
- Subject has life expectancy of less than 12 months.
- Subject is pregnant or breastfeeding.
- Subject is enrolled or planning to enroll in a concurrent clinical study that may confound the results of this study, without documented pre-approval from a Medtronic study manager.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Observational Treatment Arm
|
CRT-D programmed for LOT-CRT (LBBAP + LV lead ON) ICD programmed for LBBAP |
|
Experimentell: Sequence 1
LBBAP therapy for 6 months followed by LOT-CRT for 6 months |
CRT-D programmed for LBBAP (LV lead OFF) CRT-D programmed for LOT-CRT (LBBAP + LV lead ON) |
|
Experimentell: Sequence 2
LOT-CRT for 6 months followed by LBBAP therapy for 6 months |
CRT-D programmed for LBBAP (LV lead OFF) CRT-D programmed for LOT-CRT (LBBAP + LV lead ON) |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Left ventricular ejection fraction (LVEF)
Tidsram: Baseline, 6 months, 12 months
|
Change in LVEF assessed by echocardiography during each therapy period (baseline to 6 months, 6 months to 12 months). |
Baseline, 6 months, 12 months
|
|
Left ventricular end-systolic volume (LVESV)
Tidsram: Baseline, 6 months, 12 months
|
Change in LVESV assessed by echocardiography during each therapy period (baseline to 6 months, 6 months to 12 months). |
Baseline, 6 months, 12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Left ventricular ejection fraction (LVEF)
Tidsram: Baseline, 6 months
|
Change in LVEF assessed by echocardiography from baseline to 6 months |
Baseline, 6 months
|
|
Left ventricular end-systolic volume (LVESV)
Tidsram: Baseline, 6 months
|
Change in LVESV assessed by echocardiography from baseline to 6 months. |
Baseline, 6 months
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MDT25031
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .